Back

Safety of emergency pretreatment regimen for contrast allergy before percutaneous coronary intervention for ST-elevation myocardial infarction

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 7 - Coronary Intervention Adjunctive Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Kunal Jha

Geisinger Medical Center, Danville (United States of America)

6 More presentations in this session

Presentation thumbnail
Impact of chronic kidney disease on clinical outcomes in patients with unprotected left main coronary artery disease: insights from a large-sized all-comers registry
Assistant Professor D. Kim (Daejeon, KR)
Abstract Slides
Presentation thumbnail
Clinical outcomes of dialysis patients treated with current generation DES for left main distal bifurcation
Doctor Y. Watanabe (Matsudo, JP)
Abstract Slides
Presentation thumbnail
Evidence-practice gap in the preprocedural risk assessment for contrast-induced acute kidney injury
Doctor S. Shoji (Durham, US)
Abstract Slides
Presentation thumbnail
Trimetazidine and nicorandil decrease the increment of serum creatinine in patients with normal or slightly decreased renal function after undergoing elective percutaneous coronary intervention
Professor F. An (Jinan, CN)
Abstract Slides
Presentation thumbnail
Proenkephalin as a new glomerular filtration marker for rule-out of sustained kidney injury after cardiac catheterization: main results from the prospective PANCAKE study
Doctor J. Geng (Hamburg, DE)
Abstract

Access the full session

Session thumbnail
Poster Session 7 - Coronary Intervention

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Presentation
Percutaneous intervention is better than surgery in real life for most patients: pro
thumbnail
Congress Presentation
State-of-the-art lecture on adjunctive antiplatelet therapy for patients undergoing percutaneous coronary intervention
thumbnail
Congress Presentation
Association of PCI with outcomes in stable coronary artery disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources